Designed by
Title
Bevacizumab monoclonal antibody drug. Angiogenesis inhibitor targeting VEGF-A, used to treat cancer and age-related macular #186834001
Description
Bevacizumab monoclonal antibody drug. Angiogenesis inhibitor targeting VEGF-A, used to treat cancer and age-related macular degeneration (AMD). Generic name and stylized antibody representation